Stock 300404 BOJI MEDICAL TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Boji Medical Technology Co.,Ltd.

Equities

300404

CNE100001Y00

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
8.07 CNY -4.50% Intraday chart for Boji Medical Technology Co.,Ltd. +4.40% -9.83%
04-25 Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023 CI
04-24 Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2020 2021 2022 2024 2025
Capitalization 1 2,513 3,616 2,881 3,061 -
Enterprise Value (EV) 1 2,513 3,616 2,881 3,061 3,061
P/E ratio 149 x 87.1 x 104 x 30.5 x 24.5 x
Yield - - - 0.37% 0.5%
Capitalization / Revenue - - - 3.2 x 2.49 x
EV / Revenue - - - 3.2 x 2.49 x
EV / EBITDA - - - 19.8 x 16.4 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - - - 2.76 x 2.49 x
Nbr of stocks (in thousands) 317,267 366,000 368,352 379,338 -
Reference price 2 7.921 9.879 7.820 8.070 8.070
Announcement Date 26/04/21 25/04/22 25/04/23 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2024 2025
Net sales 1 - - - 957.1 1,230
EBITDA 1 - - - 155 187
EBIT 1 - - - 120 155
Operating Margin - - - 12.54% 12.6%
Earnings before Tax (EBT) 1 - - - 120 155
Net income 1 16.99 38.88 27.67 100.5 127.5
Net margin - - - 10.5% 10.37%
EPS 2 0.0533 0.1134 0.0753 0.2650 0.3300
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - - - 0.0300 0.0400
Announcement Date 26/04/21 25/04/22 25/04/23 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2024 2025
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - - - 8.98% 10.3%
ROA (Net income/ Total Assets) - - - 5.9% 6.6%
Assets 1 - - - 1,703 1,932
Book Value Per Share 2 - - - 2.920 3.240
Cash Flow per Share 2 - - - 0.1500 0.1700
Capex 1 - - - 47 46
Capex / Sales - - - 4.91% 3.74%
Announcement Date 26/04/21 25/04/22 25/04/23 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.07 CNY
Average target price
11.74 CNY
Spread / Average Target
+45.48%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BOJI MEDICAL TECHNOLOGY CO.,LTD. Stock Boji Medical Technology Co.,Ltd.
-9.83% 424M
MODERNA, INC. Stock Moderna, Inc.
+17.96% 44.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.17% 42.65B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.42% 26.08B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.39% 19.03B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.86% 12.75B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.29% 12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.50% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 300404 Stock
  4. Financials Boji Medical Technology Co.,Ltd.